These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 2457307)
1. Plasmin-alpha 2-plasmin inhibitor complex in plasma of patients with disseminated intravascular coagulation. Takahashi H; Hanano M; Takizawa S; Tatewaki W; Shibata A Am J Hematol; 1988 Jul; 28(3):162-6. PubMed ID: 2457307 [TBL] [Abstract][Full Text] [Related]
2. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation. Assessment by the thrombin-antithrombin-III complex/plasmin-alpha-2-antiplasmin complex ratio. Kario K; Matsuo T; Kodama K; Matsuo M; Yamamoto K; Kobayashi H Haemostasis; 1992; 22(4):179-86. PubMed ID: 1468720 [TBL] [Abstract][Full Text] [Related]
3. [Coagulation and fibrinolysis parameters in disseminated intravascular coagulation (DIC)]. Nakagawa T; Saito H; Watanabe Y; Sato M; Murakawa E Rinsho Byori; 1991 Mar; 39(3):309-14. PubMed ID: 1828842 [TBL] [Abstract][Full Text] [Related]
4. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alpha-2-plasmin inhibitor-plasmin complexes. Brower MS; Harpel PC Blood; 1983 May; 61(5):842-9. PubMed ID: 6219725 [TBL] [Abstract][Full Text] [Related]
5. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC]. Okajima K Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283 [TBL] [Abstract][Full Text] [Related]
6. Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC. Matsuda T; Asakura H; Ito K; Saito M; Jokaji Y; Uotani C; Kumabashiri I Thromb Res Suppl; 1988; 8():143-51. PubMed ID: 3144764 [TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C; Iijima K; Nakamura K Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [TBL] [Abstract][Full Text] [Related]
8. Study of the balance between coagulation and fibrinolysis in disseminated intravascular coagulation using molecular markers. Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Morishita E; Yamazaki M; Aoshima K; Matsuda T Blood Coagul Fibrinolysis; 1994 Oct; 5(5):829-32. PubMed ID: 7865691 [TBL] [Abstract][Full Text] [Related]
9. [Analysis of the fibrinolytic response on disseminated intravascular coagulation]. García Frade LJ; García Avello A Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611 [No Abstract] [Full Text] [Related]
10. Plasmin-alpha 2-antiplasmin complexes in bleeding disorders characterized by primary or secondary fibrinolysis. Booth NA; Bennett B Br J Haematol; 1984 Apr; 56(4):545-56. PubMed ID: 6201189 [TBL] [Abstract][Full Text] [Related]
11. Thrombin vs. plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Takahashi H; Tatewaki W; Wada K; Hanano M; Shibata A Am J Hematol; 1990 Feb; 33(2):90-5. PubMed ID: 1689102 [TBL] [Abstract][Full Text] [Related]
12. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators]. Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051 [No Abstract] [Full Text] [Related]
13. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers. Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863 [TBL] [Abstract][Full Text] [Related]
15. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome. Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425 [TBL] [Abstract][Full Text] [Related]
16. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients. Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260 [TBL] [Abstract][Full Text] [Related]
17. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system. Holvoet P; de Boer A; Verstreken M; Collen D Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)]. Aoki N; Takenaga T; Hasegawa H; Oguma Y; Kobayashi N; Sakata Y; Fujimaki M; Ikematsu S; Kuroso K; Matsuda T Rinsho Byori; 1987 Nov; 35(11):1275-81. PubMed ID: 2965268 [No Abstract] [Full Text] [Related]
19. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay. Harpel PC J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634 [TBL] [Abstract][Full Text] [Related]